Who owns SOLENO THERAPEUTICS INC?
- Ticker: SLNO
- CUSIP Number: 834203309
Tip: Access positions for across all investors
Analyze quarterly positions in Soleno Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Soleno Therapeutics stock
Who bought or sold SOLENO THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Vivo Capital | 8.4M | $360M | 0% | Mar 2024 |
|
Perceptive Advisors | 3.1M | $124M | 0% | Dec 2023 |
|
Carlyle | 2.9M | $115M | 25% | Dec 2023 |
|
Nantahala Capital Management | 2.9M | $115M | 628% | Dec 2023 |
|
Henderson Group | 2.5M | $102M | 15% | Dec 2023 |
|
Vanguard Group | 970k | $39M | 1655% | Dec 2023 |
|
Balyasny Asset Management | 927k | $37M | 102% | Dec 2023 |
|
venBio Select Advisor | 785k | $32M | 100% | Dec 2023 |
|
Commodore Capital | 700k | $28M | -21% | Dec 2023 |
|
Ikarian Capital | 611k | $25M | 14% | Dec 2023 |
|
Frazier Life Sciences Management | 465k | $19M | 0% | Dec 2023 |
|
Samlyn Capital | 302k | $12M | 100% | Dec 2023 |
|
Emerald Advisers | 252k | $10M | 1% | Dec 2023 |
|
Wellington Management Company | 213k | $8.6M | 100% | Dec 2023 |
|
Emerald Mutual Fund Advisers, Trust | 201k | $8.1M | 0% | Dec 2023 |
|
Allspring Global Investments Holdings | 104k | $4.4M | 100% | Mar 2024 |
|
683 Capital Management | 87k | $3.5M | 0% | Dec 2023 |
|
J. Goldman & Co | 73k | $2.9M | 11% | Dec 2023 |
|
Goldman Sachs Group | 69k | $2.8M | 100% | Dec 2023 |
|
Schonfeld Strategic Advisors | 61k | $2.5M | 162% | Dec 2023 |
|
Bank of America Corporation | 58k | $2.3M | 1374% | Dec 2023 |
|
Cubist Systematic Strategies | 57k | $2.3M | 100% | Dec 2023 |
|
Jane Street | 46k | $1.8M | 100% | Dec 2023 |
|
Citigroup | 34k | $1.4M | 32873% | Dec 2023 |
|
Swiss National Bank | 23k | $918k | 100% | Dec 2023 |
|
Barclays | 21k | $858k | 100% | Dec 2023 |
|
Dimensional Fund Advisors | 21k | $835k | 0% | Dec 2023 |
|
AWM Investment Company | 20k | $805k | 100% | Dec 2023 |
|
Caption Management | 20k | $805k | 100% | Dec 2023 |
|
ALPS Advisors | 20k | $784k | 100% | Dec 2023 |
|
UBS Group | 18k | $716k | 100% | Dec 2023 |
|
Millennium Management | 14k | $551k | -75% | Dec 2023 |
|
Credit Suisse | 13k | $517k | 100% | Dec 2023 |
|
Citadel Advisors | 13k | $503k | -69% | Dec 2023 |
|
Aspiriant | 12k | $519k | 0% | Mar 2024 |
|
Cannon Global Investment Management | 12k | $505k | 100% | Mar 2024 |
|
State of Wisconsin Investment Board | 9.5k | $382k | 100% | Dec 2023 |
|
Legal & General Group | 7.7k | $311k | 100% | Dec 2023 |
|
Charles Schwab Investment Management | 7.2k | $290k | 100% | Dec 2023 |
|
Squarepoint Ops | 6.9k | $278k | 100% | Dec 2023 |
|
Captrust Financial Advisors | 6.1k | $244k | -41% | Dec 2023 |
|
Cutler | 3.5k | $3.1k | 100% | Mar 2024 |
|
Virtus ETF Advisers | 2.5k | $100k | 100% | Dec 2023 |
|
ADAR1 Capital Management | 1.1k | $44k | 100% | Dec 2023 |
|
Jpmorgan Chase & Co | 681.00 | $27k | -98% | Dec 2023 |
|
VisionPoint Advisory Group | 168.00 | $6.8k | 0% | Dec 2023 |
|
New York State Common Retirement Fund | 137.00 | $6.0k | 100% | Dec 2023 |
|
Wells Fargo & Company | 115.00 | $4.6k | 248% | Dec 2023 |
|
Advisor Group Holdings | 71.00 | $2.9k | 0% | Dec 2023 |
|
Global Retirement Partners | 70.00 | $3.0k | 100% | Mar 2024 |
|
Harbour Investments | 5.00 | $201.000000 | 100% | Dec 2023 |
|
Who sold out of Soleno Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
RA Capital Management | Sep 2023 | 1.2M | $37M |
Fairmount Funds Management | Sep 2023 | 1.1M | $34M |
Soleus Capital Management | Sep 2023 | 325k | $9.6M |
Logos Global Management | Sep 2023 | 125k | $3.7M |
Moore Capital Management | Sep 2023 | 50k | $1.5M |
Walleye Trading Advisors | Sep 2023 | 46k | $1.4M |
Maven Securities | Sep 2023 | 25k | $738k |
Bank of New York Mellon | Dec 2023 | 9.9k | $400k |
Sassicaia Capital Advisers | Sep 2023 | 8.7k | $255k |
Clayton Partners | Sep 2023 | 7.0k | $207k |
Simplex Trading | Dec 2023 | 4.2k | $168k |